This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Thomas William Burns net worth and biography

Thomas Burns Biography and Net Worth

CEO of Glaukos

Mr. Burns has served as our chief executive officer and as a member of our Board of Directors since March 2002. In December 2021, he was appointed Chairman of the Board. He also previously served as our president from March 2002 to March 2022. Mr. Burns was also a founder and member of the board of directors of DOSE Medical Corporation (acquired by Glaukos), serving as its chairman of the board from October 2009 until June 2019 and its chief executive officer and president from March 2010 until June 2015. Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. He has raised nearly $400 million in enterprise capital in private and public offerings and has led and helped build multiple start-up companies. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices and pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Prior to joining our Company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer and as a director. From 1990 to 1997, Mr. Burns served as senior vice president and general manager of Chiron Vision Corporation (acquired by Bausch & Lomb, Inc.), and then as vice president, global strategy and general manager, refractive surgery, of Bausch & Lomb from 1998 to 2000. In October 2020, Mr. Burns joined the board of directors of Pulmonx Corporation (Nasdaq: LUNG). He served on the board of directors of Avedro from July 2018 until his resignation on August 6, 2019, prior to its acquisition by Glaukos. Mr. Burns has also served as an entrepreneur in residence at Versant Ventures Management, LLC. Mr. Burns received a B.A. from Yale University.

What is Thomas William Burns' net worth?: The estimated net worth of Thomas William Burns is at least $7.90 million as of January 8th, 2024. Mr. Burns owns 55,835 shares of Glaukos stock worth more than $7,897,302 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Burns may own. Additionally, Mr. Burns receives a salary of $774,900.00 as CEO at Glaukos. Learn More about Thomas William Burns' net worth.
How old is Thomas William Burns?: Mr. Burns is currently 63 years old. There are 5 older executives and no younger executives at Glaukos. The oldest executive at Glaukos is Ms. Jane E. Rady, Senior Vice President of Corporate Strategy & Business Development, who is 76 years old. Learn More on Thomas William Burns' age.
What is Thomas William Burns' salary?: As the CEO of Glaukos Co., Mr. Burns earns $774,900.00 per year. There are 2 executives that earn more than Mr. Burns. The highest earning executive at Glaukos is Mr. Joseph E. Gilliam, President & COO, who commands a salary of $1,180,000.00 per year. Learn More on Thomas William Burns' salary.
How do I contact Thomas William Burns?: The corporate mailing address for Mr. Burns and other Glaukos executives is 229 AVENIDA FABRICANTE, SAN CLEMENTE CA, 92672. Glaukos can also be reached via phone at (949) 367-9600 and via email at [email protected]. Learn More on Thomas William Burns' contact information.
Has Thomas William Burns been buying or selling shares of Glaukos?: Thomas William Burns has not been actively trading shares of Glaukos over the course of the past ninety days. Most recently, Thomas William Burns sold 60,000 shares of the business's stock in a transaction on Monday, January 8th. The shares were sold at an average price of $82.55, for a transaction totalling $4,953,000.00. Following the completion of the sale, the chief executive officer now directly owns 55,835 shares of the company's stock, valued at $4,609,179.25. Learn More on Thomas William Burns' trading history.
Who are Glaukos' active insiders?: Glaukos' insider roster includes Thomas Burns (CEO), Mark Foley (Director), Joseph Gilliam (CFO), Gilbert Kliman (Director), Marc Stapley (Director), Alex Thurman (CFO), and Aimee Weisner (Director). Learn More on Glaukos' active insiders.
Are insiders buying or selling shares of Glaukos?: During the last year, insiders at the medical instruments supplier sold shares 40 times. They sold a total of 554,220 shares worth more than $51,062,568.73. The most recent insider tranaction occured on October, 30th when COO Joseph E Gilliam sold 2,275 shares worth more than $316,156.75. Insiders at Glaukos own 6.4% of the company. Learn More about insider trades at Glaukos.
Information on this page was last updated on 10/30/2024.

Thomas William Burns Insider Trading History at Glaukos

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/8/2024	Sell	60,000	$82.55	$4,953,000.00	55,835
12/21/2023	Sell	79,684	$85.21	$6,789,873.64	55,835
12/15/2023	Sell	60,000	$80.94	$4,856,400.00	55,835
10/2/2023	Sell	45,000	$71.98	$3,239,100.00	54,785
7/19/2023	Sell	200	$80.01	$16,002.00	673,963
7/14/2023	Sell	30,000	$77.95	$2,338,500.00	673,963
7/10/2023	Sell	13,440	$70.87	$952,492.80	673,963
7/7/2023	Sell	133	$70.00	$9,310.00	673,963
7/5/2023	Sell	5,027	$70.02	$351,990.54	673,963
7/3/2023	Sell	26,400	$69.51	$1,835,064.00	673,963
6/28/2023	Sell	26,810	$70.19	$1,881,793.90	673,963
6/7/2023	Sell	17,382	$67.20	$1,168,070.40	673,963
6/2/2023	Sell	142	$60.00	$8,520.00	673,963
5/23/2023	Sell	7	$60.00	$420.00	673,963
5/18/2023	Sell	11,662	$60.17	$701,702.54	673,963
5/16/2023	Sell	3,704	$60.01	$222,277.04	673,963
5/26/2020	Sell	207,447	$39.23	$8,138,145.81
5/20/2020	Sell	400	$38.05	$15,220.00
8/7/2018	Sell	150,000	$38.78	$5,817,000.00
9/7/2017	Sell	73,788	$41.36	$3,051,871.68
9/5/2017	Sell	1,212	$41.25	$49,995.00
2/2/2017	Sell	50,000	$42.58	$2,129,000.00
1/9/2017	Sell	40,000	$37.60	$1,504,000.00
11/15/2016	Sell	200,120	$33.68	$6,740,041.60	1,388
7/13/2016	Sell	162,254	$30.07	$4,878,977.78	1,388
6/20/2016	Sell	7,997	$30.00	$239,910.00	1,388
6/6/2016	Sell	24,578	$25.16	$618,382.48	1,388
6/3/2016	Sell	422	$25.00	$10,550.00	1,388
6/1/2016	Sell	25,000	$23.90	$597,500.00	1,388
5/25/2016	Sell	300	$25.00	$7,500.00	1,388
5/4/2016	Sell	36,700	$24.67	$905,389.00	1,388

Thomas William Burns Buying and Selling Activity at Glaukos

Glaukos Company Overview

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $141.44

$139.87

$144.50

50 Day Range

MA: $131.75

$121.58

$144.10

2 Week Range

Now: $141.44

$59.22

$145.84

Volume

362,127 shs

Average Volume

573,926 shs

Market Capitalization

$7.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad

Click here and I’ll tell you everything you need to know.

Thomas Burns Biography and Net Worth

What is Thomas William Burns' net worth?

How old is Thomas William Burns?

What is Thomas William Burns' salary?

How do I contact Thomas William Burns?

Has Thomas William Burns been buying or selling shares of Glaukos?

Who are Glaukos' active insiders?

Are insiders buying or selling shares of Glaukos?